Has Nowreen Haq, MD received payments from drug or device companies?

Yes. Drug and device makers reported $85,455 in general payments to Nowreen Haq, MD across 348 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nowreen Haq, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nowreen Haq, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nowreen Haq, MD

Endocrinology, Diabetes & Metabolism · Baltimore, MDNPI 1114123395

Payments from drug & device makers

$85,455in general payments, 2019–2025

Across 348 payments — averaging $245.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$38K
Recordati_rare_diseases_inc.$21K
Corcept Therapeutics$18K
Amgen$2K
Medtronic$1K
Lilly USA, LLC$724
plus $5K from 36 others

$61,568in research payments, 2019–2025

Across 6 payments — averaging $10,261 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bayer$62K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	55	$38,133
Recordati_rare_diseases_inc.	4	$21,033
Corcept Therapeutics	30	$18,161
Amgen(2 entities)	12	$1,575
Medtronic(2 entities)	14	$1,156
Lilly USA, LLC	46	$724
Xeris Pharmaceuticals, Inc.	32	$677
Novo Nordisk	21	$574
Sanofi-aventis U.S. LLC	19	$487
AstraZeneca(2 entities)	16	$486
Dexcom, Inc.	10	$401
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	20	$261
Kyowa Kirin, Inc.	4	$191
Sanofi	1	$185
Biogen	7	$172
Novartis	9	$162
Abbott	4	$135
Cequr Corporation	3	$109
Esperion Therapeutics, Inc.	4	$75
Tandem Diabetes Care, Inc.	3	$62
Ascensia Diabetes Care US Inc.	2	$61
AbbVie	3	$60
Pfizer	3	$54
Mannkind Corporation	2	$52
Radius Health, Inc.	3	$51
Amneal Pharmaceuticals LLC	3	$51
Averitas Pharma Inc.	1	$30
Merck	2	$30
Johnson & Johnson	1	$29
Insulet Corporation	2	$28
Soleno Therapeutics, Inc.	1	$28
Boehringer Ingelheim	1	$27
Embecta Corp.	1	$27
Actelion Pharmaceuticals US, Inc.	1	$23
Endo Pharmaceuticals Inc.	1	$20
Amryt Pharma Holdings Ltd	1	$20
Rhythm Pharmaceuticals, Inc.	1	$19
Otsuka America Pharmaceutical, Inc.	1	$19
IBSA Pharma Inc.	1	$18
Irhythm Technologies, Inc.	1	$18
Nestle Healthcare Nutrition Inc.	1	$16
Chiesi USA, Inc.	1	$14

How this compares

$85,455 in reported general payments places this provider in the 90th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.

See all endocrinology, diabetes & metabolism providers in Maryland →

Medicare billing

Part B allowed, 2024

$83,897

Medicare patients

225

Services billed

1,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Baltimore

Jean ParkBaltimore$3.7M
Ilias SpanakisBaltimore$2.6M
Philip LevinBaltimore$702K
Roberto SalvatoriBaltimore$403K
Thomas DonnerBaltimore$197K
Adrian DobsBaltimore$190K
Todd BrownBaltimore$143K
Nanette SteinleBaltimore$74K
Paul SackBaltimore$69K
Asif MohamedBaltimore$31K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →